“This flew in the face of vaccine dogma,” Kreimer said. At the time, researchers thought protein-based vaccines like Cervarix always needed at least two doses to result in a durable resul ...

Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is ...

Regardless of what certain politicians may believe, there's an easy way to prevent all of this: the Gardasil and Cervarix ...

Ninety-nine percent of cervical cancers are caused by HPV. What is the Cervarix HPV vaccine? The Cervarix HPV vaccine protects against the two strains of HPV (16 and 18) that cause cervical cancer ...

GSK says it plans to seek FDA approval for Cervarix by the end of the year. Early studies find that this vaccine, like Gardasil, is extremely safe and effective. GlaxoSmithKline is a WebMD sponsor.

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized trial showed. In the ESCUDDO trial, which involved more than 20,000 ...

This Cervarix market report delivers an in-depth ... Key trends in the forecast period include the development of next-generation HPV vaccines, the adoption of combination vaccines, improvements ...

(Alliance News) - GSK PLC on Friday said China's National Medical Products Administration has approved the use of its HPV vaccine Cervarix for girls aged 9 to 14. The pharmaceutical firm said that ...

In the ESCUDDO trial, which involved more than 20,000 girls ages 12 to 16, one dose of both the bivalent Cervarix and 9-valent Gardasil 9 HPV vaccines provided similar protection to two doses ...